Elanco Animal Health ELAN
NYSE ELAN
$23.60 -0.90 (-3.65%)
At close: Aug 20, 2026 · 12:58 PM UTC

Elanco Animal Health (ELAN) Asset Writedowns and Impairment (2017 - 2025)

Elanco Animal Health (ELAN) posted Asset Writedowns and Impairment of $47.0 million for Q4 2025, up 95.83% sequentially from $24.0 million in Q3 2025, and up 840.0% YoY from $5.0 million in Q4 2024.

Elanco Animal Health (ELAN) Asset Writedowns and Impairment (2017 - 2025) Analysis & Trends

Elanco Animal Health has reported Asset Writedowns and Impairment for 9 years, with the latest figure at $47.0 million in Q4 2025.

  • Quarterly Asset Writedowns and Impairment rose 840.0% year-over-year to $47.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $91.0 million (up 75.0% YoY) and the FY2025 annual result came in at $71.0 million, down 12.35% from the prior year.
  • Asset Writedowns and Impairment grew to $47.0 million in Q4 2025 per ELAN's latest filing, from $24.0 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $275.0 million in Q2 2021 and troughed at $5.0 million in Q4 2021.
  • A 5-year average of $45.8 million and a median of $23.0 million in 2022 frame the typical range for Asset Writedowns and Impairment.
  • The sharpest annual moves came in 2021 and 2024: Asset Writedowns and Impairment jumped 9066.67% in 2021, then slumped 81.48% in 2024.
  • Over 5 years, Asset Writedowns and Impairment stood at $5.0 million in 2021, then surged by 1080.0% to $59.0 million in 2022, then slumped by 54.24% to $27.0 million in 2023, then tumbled by 81.48% to $5.0 million in 2024, then soared by 840.0% to $47.0 million in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $47.0 million, $24.0 million, and $5.0 million for Q4 2025, Q3 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.96 Bn 43.00 Bn -
2 Teva Pharmaceutical Industries 43.23 Bn 39.58 Bn 2.15 Bn
3 Zoetis 31.76 Bn 30.08 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn
6 Viatris 18.69 Bn 17.81 Bn 1.46 Bn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn
8 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn -
10 Alkermes 8.14 Bn 7.48 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 47.00 Mn
Dec 31, 2025 47.00 Mn
Sep 30, 2025 24.00 Mn
Sep 30, 2025 24.00 Mn
Dec 31, 2024 5.00 Mn
Dec 31, 2024 5.00 Mn
Sep 30, 2024 15.00 Mn
Sep 30, 2024 15.00 Mn
Dec 31, 2023 27.00 Mn
Dec 31, 2023 27.00 Mn
Sep 30, 2023 5.00 Mn
Sep 30, 2023 5.00 Mn
Jun 30, 2022 59.00 Mn
Jun 30, 2022 59.00 Mn
Mar 31, 2022 22.00 Mn
Mar 31, 2022 22.00 Mn
Dec 31, 2021 5.00 Mn
Dec 31, 2021 5.00 Mn
Sep 30, 2021 56.00 Mn
Sep 30, 2021 56.00 Mn